FDAapproval83% confidence
Competitive Generic Therapy Approvals
Source: FDA
Why This Matters
Why this matters: sets a approval precedent in the same sub-indication (cardiology) as AstraZeneca's Baxfendy Receives US Approval for Hypertension as First-in-Class T.
Regulatory Analysis
Explore the FDA’s Competitive Generic Therapy Approvals page, offering insights into the program designed to encourage generic drug competition. Access information about approved CGT products and find resources, including a downloadable CGT approvals spreadsheet.
Supporting Context
- Therapeutic area
- Cardiology · Hypertension
- Sub-indication
- Hypertension
Related signal: AstraZeneca's Baxfendy Receives US Approval for Hypertension as First-in-Class Treatment
Source
FDA document
View source